About 908 devices inc - MASS
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Burlington, MA.
MASS At a Glance
908 Devices, Inc.
44 Third Avenue
Burlington, Massachusetts 01803
| Phone | 1-857-254-1500 | Revenue | 59.63M | |
| Industry | Medical Specialties | Net Income | -72,206,000.00 | |
| Sector | Health Technology | 2024 Sales Growth | 18.718% | |
| Fiscal Year-end | 12 / 2025 | Employees | 246 | |
| View SEC Filings |
MASS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.257 |
| Price to Book Ratio | 0.674 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.422 |
| Enterprise Value to Sales | 0.201 |
| Total Debt to Enterprise Value | 0.552 |
MASS Efficiency
| Revenue/Employee | 242,402.439 |
| Income Per Employee | -293,520.325 |
| Receivables Turnover | 4.722 |
| Total Asset Turnover | 0.329 |
MASS Liquidity
| Current Ratio | 4.098 |
| Quick Ratio | 3.455 |
| Cash Ratio | 2.768 |
MASS Profitability
| Gross Margin | 45.889 |
| Operating Margin | -55.449 |
| Pretax Margin | -121.561 |
| Net Margin | -121.088 |
| Return on Assets | -39.843 |
| Return on Equity | -51.56 |
| Return on Total Capital | -59.576 |
| Return on Invested Capital | -50.012 |
MASS Capital Structure
| Total Debt to Total Equity | 5.766 |
| Total Debt to Total Capital | 5.451 |
| Total Debt to Total Assets | 4.143 |
| Long-Term Debt to Equity | 4.138 |
| Long-Term Debt to Total Capital | 3.913 |